144
0001363364
XXXXXXXX
LIVE
0001359931
Protara Therapeutics, Inc.
001-36694
345 Park Avenue South
Third Floor
New York
NY
10010
646-844-0337
Baker Brothers Life Sciences, L.P.
Former Affiliate
Common Stock
Jefferies LLC
520 Madison Avenue
New York
NY
10022
300176
1605942.00
55060500
04/23/2026
NASDAQ
Common Stock
09/22/2020
See Remark 2
Underwriter
N
300176
09/24/2020
See Remark 2
N
Baker Brothers Life Sciences, L.P.
860 Washington Street, 3rd Floor
New York
NY
10014
Common Stock
02/24/2026
322039
1944922.00
Baker Brothers Life Sciences, L.P.
860 Washington Street, 3rd Floor
New York
NY
10014
Common Stock
02/25/2026
947479
5501316.00
Baker Brothers Life Sciences, L.P.
860 Washington Street, 3rd Floor
New York
NY
10014
Common Stock
03/04/2026
424125
2654641.00
Baker Brothers Life Sciences, L.P.
860 Washington Street, 3rd Floor
New York
NY
10014
Common Stock
03/06/2026
461723
2701080.00
(1) Baker Brothers Life Sciences, L.P. is affiliated with 667, L.P. Baker Bros. Advisors LP is the investment adviser to 667, L.P. and Baker Brothers Life Sciences, L.P. 667, L.P. is filing separately for the sale of 24,802 shares of common stock ("Common Stock") of Protara Therapeutics, Inc. (the "Issuer"), which along with the reported sales in this form by Baker Brothers Life Sciences, L.P. totals 324,978 shares of Common Stock. (2) Common Stock converted from Series 1 Preferred.
04/23/2026
By: BAKER BROS. ADVISORS LP, mgmt company and IA to Baker Brothers Life Sciences, L.P., /s/ Scott L. Lessing, President